Professor, Director of Research Laboratory of Reproductive Genetics.
Resident Doctor.
Obstet Gynecol Surv. 2021 Apr;76(4):234-244. doi: 10.1097/OGX.0000000000000887.
Postpartum hemorrhage (PPH) is an emergent obstetric complication and the leading cause of maternal mortality. Pelvic arterial embolization (PAE) is an effective treatment for intractable PPH. However, a unique protocol has not been accepted in obstetrical practice.
To evaluate its efficiency, safety, complications, and outcomes, we conducted a systematic review and meta-analysis of PAE for PPH in the literature.
The Medline, the database of abstract of reviews, the index to allied health literature, and the Chinese database Sino-Med were searched on March 31, 2020, for studies on PAE for PPH. The data for PAE indication, agents, arteries, success rate, complications, and outcomes were extracted and syncretized for meta-analysis.
From 1075 identified articles, 113 abstracts or full articles were retrieved and 43 studies were finally identified as meeting the including criteria. The results demonstrated that the indications for PAE were as follows: uterine atony, placental abnormality, delivery tract injury, disseminated intravascular coagulation, arteriovenous malformation, and vaginal hematoma. The embolization agents mostly in order were gelatin sponge particles, polyvinyl alcohol particles, Gelfoam, -butyl cyanoacrylate, microcoil, and glue; for arteries, they were mostly uterine artery and internal iliac artery. The clinical success rate was 90.5%, whereas the technical success rate was 99.3%. The most common complications of PAE were postembolization syndrome and menstrual abnormality.
The emergent PAE is a safe and effective method with high success rate in life-threatening PPH management. Gelatin sponge granules measuring 500 to 1000 μm in diameter have safe results. Pelvic arterial embolization may affect the recovery of menses and increase PPH in the subsequent pregnancy, but there was no noted correlation with fetal growth restriction.
产后出血(PPH)是一种紧急的产科并发症,也是产妇死亡的主要原因。骨盆动脉栓塞(PAE)是治疗难治性 PPH 的有效方法。然而,在产科实践中尚未接受独特的方案。
为了评估 PAE 治疗 PPH 的效率、安全性、并发症和结局,我们对文献中 PAE 治疗 PPH 进行了系统评价和荟萃分析。
2020 年 3 月 31 日,检索了 Medline、评论摘要数据库、联合卫生文献索引和中国数据库 Sino-Med,以获取关于 PAE 治疗 PPH 的研究。提取和合并 PAE 适应证、药物、动脉、成功率、并发症和结局的数据进行荟萃分析。
从 1075 篇鉴定文章中,检索到 113 篇摘要或全文,最终确定 43 项研究符合纳入标准。结果表明,PAE 的适应证如下:子宫收缩乏力、胎盘异常、分娩道损伤、弥漫性血管内凝血、动静脉畸形和阴道血肿。栓塞剂主要是明胶海绵颗粒、聚乙烯醇颗粒、Gelfoam、氰基丙烯酸丁酯、微线圈和胶;动脉主要是子宫动脉和髂内动脉。临床成功率为 90.5%,而技术成功率为 99.3%。PAE 最常见的并发症是栓塞后综合征和月经异常。
紧急 PAE 是一种安全有效的方法,在危及生命的 PPH 管理中成功率高。直径 500 至 1000μm 的明胶海绵颗粒结果安全。骨盆动脉栓塞可能会影响月经恢复并增加后续妊娠的 PPH,但与胎儿生长受限无明显相关性。